HomeInsightsStock Comparison

Amwill Health Care Ltd vs Bajaj Healthcare Ltd Stock Comparison

Amwill Health Care Ltd vs Bajaj Healthcare Ltd Stock Comparison

Last Updated on: Jul 16, 2025

Key Highlights

  • The Latest Trading Price of Amwill Health Care Ltd is ₹ 68.81 as of 16 Jul 15:30.
  • The P/E Ratio of Amwill Health Care Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Bajaj Healthcare Ltd changed from 11.2 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years.
  • The Market Cap of Amwill Health Care Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Bajaj Healthcare Ltd changed from ₹ 283.78 crore on March 2020 to ₹ 807.25 crore on March 2024 . This represents a CAGR of 23.26% over 5 years.
  • The revenue of Amwill Health Care Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Bajaj Healthcare Ltd for the Mar '25 is ₹ 168.04 crore as compare to the Dec '24 revenue of ₹ 125.17 crore. This represent the growth of 34.25%.
  • The ebitda of Amwill Health Care Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Bajaj Healthcare Ltd for the Mar '25 is ₹ 24.91 crore as compare to the Dec '24 ebitda of ₹ 20.77 crore. This represent the growth of 19.93%.
  • The net profit of Amwill Health Care Ltd changed from ₹ 1.5 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of -100.00% The net profit of Bajaj Healthcare Ltd changed from ₹ -48.21 crore to ₹ 11.18 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Amwill Health Care Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Bajaj Healthcare Ltd changed from 4.57 % on March 2021 to -3.29 % on March 2024 . This represents a CAGR of NaN% over 4 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Amwill Health Care Ltd

  • Amwill Health Care Limited was originally incorporated on August 21, 2017 under the name Amwill Health Care Private Limited', dated August 22, 2017 issued by the Deputy Registrar of Companies, Karnataka at Bangalore.
  • Further, Company was converted into a Public Limited Company and a fresh Certificate of Incorporation dated January 25, 2024 was issued by the Registrar of Companies, Karnataka at Bangalore with the change in name to Amwill Health Care Limited'. Amwill Health Care Ltd is a derma-cosmetic development company, associated with contract manufacturers, distributor and third party product development agencies, which has enabled in developing capabilities, in manufacturing, packaging and distribution.
  • The core focus of Company is on development of problem solving dermatological, cosmeceutical and aesthetical products, and therefore to direct all efforts towards product formulation and development, the Company has outsourced key functions such as manufacturing, prototype development and distribution to third parties, for effective management and execution.

About Bajaj Healthcare Ltd

  • Incorporated in 1993, Maharashtra-based Bajaj Healthcare Limited is one of India's large scale and vertically integrated pharmaceutical manufacturer for quality-conscious customers.
  • The Company is engaged in the manufacturing of Active Pharmaceutical Ingredient (APIs), Intermediates, Finished Dosage Forms & Nutraceuticals. The Company commenced its operations in 1993 with a single unit at Tarapur.
  • It became a public company in 2005 and listed its shares in the Indian stock exchanges in 2016. With Headquartered in Thane, Company has established 3 API plants in Gujarat and Maharashtra.
  • It has 4 units for APIs/ intermediates and one unit for formulation, which are designed to meet the requirements of both advanced as well as emerging market opportunities.
  • In 2008, the Company acquired Formulations plant at Manjusar, Vadodara and have converted it into WHO-GMP compliant facility.

Amwill Health Care Ltd News Hub

News

Amwill Health Care AGM scheduled

Amwill Health Care announced that the 8th Annual General Meeting(AGM) of the company will ...

Read more

09 Jul 2025 16:22

News

Amwill Health Care schedules board meeting

Amwill Health Care will hold a meeting of the Board of Directors of the Company on 29 May ...

Read more

28 May 2025 10:43

News

BSE SME Amwill Health Care drops on debut

The scrip was listed at 88.85, at a discount of 19.95% compared with the initial public of...

Read more

12 Feb 2025 10:50

Bajaj Healthcare Ltd News Hub

News

Bajaj Healthcare slides after WTD Dhananjay Sabaji Hatle resigns

Bajaj Healthcare manufactures APIs and branded and generic formulations. It has five API m...

Read more

06 Jun 2025 09:56

News

Board of Bajaj Healthcare recommends final dividend

Bajaj Healthcare announced that the Board of Directors of the Company at its meeting held ...

Read more

27 May 2025 11:38

News

Bajaj Healthcare reports turnaround Q4 numbers

However, revenue from operations jumped 15.36% year-on-year (YoY) to Rs 154.47 crore in th...

Read more

27 May 2025 10:36

News

Bajaj Healthcare to convene board meeting

Bajaj Healthcare will hold a meeting of the Board of Directors of the Company on 26 May 20...

Read more

21 May 2025 15:10

News

India Ratings revises rating outlook of Bajaj Healthcare to 'stable'; affirms rating at 'A-

The agency has affirmed the company's short-term rating at 'IND A2+'. India Ratings and Re...

Read more

16 May 2025 14:41

News

Bajaj Healthcare gains after acquiring WHO-GMP certified firm Genrx Pharma

The acquisition, valued at Rs 10.85 crore through a cash consideration, involves 100% cont...

Read more

08 Apr 2025 13:22

SWOT Analysis Of Bajaj Healthcare Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Bajaj Healthcare Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Amwill Health Care Ltd and Bajaj Healthcare Ltd

Which company has a larger market capitalization, Amwill Health Care Ltd or Bajaj Healthcare Ltd?

Market cap of Amwill Health Care Ltd is 137 Cr while Market cap of Bajaj Healthcare Ltd is 1,657 Cr

What are the key factors driving the stock performance of Amwill Health Care Ltd and Bajaj Healthcare Ltd?

The stock performance of Amwill Health Care Ltd and Bajaj Healthcare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Amwill Health Care Ltd and Bajaj Healthcare Ltd?

As of July 16, 2025, the Amwill Health Care Ltd stock price is INR ₹68.81. On the other hand, Bajaj Healthcare Ltd stock price is INR ₹524.85.

How do dividend payouts of Amwill Health Care Ltd and Bajaj Healthcare Ltd compare?

To compare the dividend payouts of Amwill Health Care Ltd and Bajaj Healthcare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions